Yonina Fleischman holds the position of ESG Access to Medicines Lead at Teva Pharmaceuticals. In her role, she leads Teva Access, a key component of Teva’s ESG strategy, whose mission is to bring sustainable solutions that expand access to Teva’s broad portfolio of medicines to improve the health of patients in need throughout the world. Teva’s access strategic donation and social business programs are largely geared specifically toward vulnerable populations with unmet need in low and middle income countries, who experience financial affordability or physical access barriers. Prior to her role at Teva, Yonina has held positions at the Israeli Ministry of Health and at a number of Israeli non-governmental organizations, with a focus on access to care and health promotion. She has also worked extensively on health promotion within the Bedouin population and the asylum seeker community in Israel. An avid traveler, Yonina has spent considerable periods of time working in the field of public health with low income communities around the world, with an emphasis on women, children and other vulnerable populations. This has included health outreach in Ghana, empowerment programming in Nepal, and community development and health advocacy in post-earthquake Haiti. Originally from the US, Yonina is now based in Israel. She holds a Master’s in Public Health from the Hebrew University of Jerusalem and a Bachelor’s in International Studies from Brandeis University.
Yonina Fleischman
